Local News Indigenous Health Equity Focus of Pathways Symposium Fred Hutch | May 27, 2022 It was a coming together of cultures — Indigenous scholars from the Lakota, the Lummi,…dcorriganMay 27, 2022 Read More
Local News Seagen Announces Positive Topline Results of Pivotal Phase II Clinical Trial of TUKYSA® (tucatinib) in Combination With Trastuzumab in HER2-Positive Metastatic Colorectal Cancer Seagen | May 27, 2022 Seagen announced positive topline results from the pivotal Phase II MOUNTAINEER clinical trial investigating TUKYSA® (tucatinib)…dcorriganMay 27, 2022 Read More
Local News Longtime UW Science Leader Nora Disis on Gender Inequity, Translational Research, and More GeekWire | May 27, 2022 Mary “Nora” L. Disis has seen a lot of change in her 30 years at…dcorriganMay 27, 2022 Read More
Publications of the Week Upregulation of Mitochondrial ATPase Inhibitory Factor 1 (ATPIF1) Mediates Increased Glycolysis in Mouse Hearts Zhou, B., et al. | May 26, 2022 The CDC estimates 6.2 million adults in the US have heart failure, which is a…dcorriganMay 26, 2022 Read More
Local News Umoja Biopharma and Lupagen Announce New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for Cancer Umoja Biopharma | May 25, 2022 Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in…dcorriganMay 25, 2022 Read More
Local News Alpine Immune Sciences Announces FDA Removes Partial Clinical Hold on NEON-2 Clinical Trial of Davoceticept (ALPN-202) in Combination with Pembrolizumab Alpine Immune Sciences | May 25, 2022 Alpine Immune Sciences, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer…dcorriganMay 25, 2022 Read More
Awards Genome and Global Health Scientists on TIME100 UW Medicine | May 25, 2022 Genome scientist Evan Eichler and global health researcher Tulio de Oliveira have been named to…dcorriganMay 25, 2022 Read More
Local News Test of a New ‘Germline-Targeting’ HIV Vaccine Prepares to Launch Fred Hutch | May 24, 2022 Since 2013, Dr. Leo Stamatatos has been developing a different kind of HIV vaccine intended…dcorriganMay 24, 2022 Read More
Publications of the Week Synthetic Lethal Kinases in Ras/p53 Mutant Squamous Cell Carcinoma Moser, R., et al. | May 23, 2022 The authors use patient-derived tumor cells to identify and validate new drug targets as well…dcorriganMay 23, 2022 Read More
Local News After Sprint for COVID-19 Vaccines, Researchers Return to HIV Marathon with Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign Fred Hutch | May 20, 2022 Building on momentum from the highly successful COVID-19 vaccine clinical trials, the HIV Vaccine Trials Network (HVTN)…dcorriganMay 20, 2022 Read More